NCT04173520View on ClinicalTrials.gov

ELRIAH Score: A Simple Score for HCC Risk Stratification in CHC Patients With Cirrhosis or Advanced Liver Fibrosis Who Achieved SVR Following DAA Therapy

CompletedOBSERVATIONAL
Enrollment

2,326

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

August 31, 2019

Study Completion Date

October 30, 2019

Conditions
HCC
Interventions
DRUG

DDA

Follow up after SVR

All Listed Sponsors
lead

Egyptian Liver Hospital

OTHER

NCT04173520 - ELRIAH Score: A Simple Score for HCC Risk Stratification in CHC Patients With Cirrhosis or Advanced Liver Fibrosis Who Achieved SVR Following DAA Therapy | Biotech Hunter | Biotech Hunter